Phenyl-prenyl-ether derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders

Details for Australian Patent Application No. 2007280400 (hide)

Owner NOSCIRA, S.A.

Inventors Martinez Gil, Ana; Delgado Hernandez, Elena; Lopez Ogalla, Javier; Garcia Palomero, Esther; Usan Egea, Paola; De Austria De Luque, Celia; Medina Padilla, Miguel; Castro Morera, Ana; Munoz Ruiz, Pilar; Garcia Fernandez, Pablo; Valenzuela Liminana, Rita; Sanchez-Quesada, Jorge; Rubio Arrieta, Laura

Agent Collison & Co

Pub. Number AU-A-2007280400

PCT Pub. Number WO2008/015241

Priority 06380222.7 01.08.06 EP

Filing date 1 August 2007

Wipo publication date 7 February 2008

International Classifications

C07C 69/92 (2006.01) Esters of carboxylic acids

A61K 31/235 (2006.01)

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07C 43/215 (2006.01) Ethers

C07C 65/28 (2006.01) Compounds having carboxyl groups bound to carbon atoms of six-membered aromatic rings and containing any of the groups OH, O-metal, CHO, keto, ether, groups, groups, or groups

C07C 229/60 (2006.01) Compounds containing amino and carboxyl groups bound to the same carbon skeleton

C07C 233/54 (2006.01) Carboxylic acid amides

C07C 235/46 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

Event Publications

26 March 2009 PCT application entered the National Phase

  PCT publication WO2008/015241 Priority application(s): WO2008/015241

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007280407-Process for preparing amorphous lercanidipine hydrochloride

2007280399-N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders